Skip to content
memoinOncology Logo memoinOncology Logo memoinOncology Logo
  • CONGRESS REPORTS
    • Solid Tumors
      • ASCO
      • EANM
      • ESMO
      • ESMO IO
      • NANETS
    • Hematology
      • ASH
      • EHA
      • ESH CLL
      • ISHL
      • iwWM
    • Lung Cancer
      • ASCO
      • CSCO
      • ECC
      • ELCC
      • ESMO
      • ESMO Asia
      • WCLC
  • MEDICAL EDUCATION
    • Clinical Trials
    • Preceptorship reports
    • Articles
  • COLLABORATIONS
    • CSCO
    • LACOG
    • SEO
    • SSO
  • SUPPORTER
    • Boehringer Ingelheim in Oncology
    • BeiGene
    • ITM
  • MORE…
    • ABOUT US
    • LINKS
    • CALENDAR
    • VIDEOS

Benefits of lung cancer mass screening in China

Benefits of lung cancer mass screening in China

Read More

Air-pollution–induced lung cancer: defining a targetable link

Air-pollution–induced lung cancer: defining a ta

Read More

Updates on immunotherapy-based treatment of stage III/IV disease

Updates on immunotherapy-based treatment of stag

Read More

Targeted approaches in the first and later lines: KRASG12C, EGFR, HER2 & angiogenesis

Targeted approaches in the first and later lines

Read More

Treatment benefits and outcome determinants in (neo)adjuvant trials

Treatment benefits and outcome determinants in (

Read More

Preface – ESMO Lung Cancer 2022

Preface – ESMO Lung Cancer 2022 © ElainePerks2013 -

Read More

Sponsors:
This website is intended only for healthcare professionals outside the US, the UK, and Australia   |   This website is supported by an unrestricted medical education grant from BeiGene, Boehringer Ingelheim and ITM
© Copyright 2012 -  memoinOncology BY SPRINGER-VERLAG GmbH   |   Projekt: infill healthcare communication GmbH.   |   Alle Rechte vorbehalten.   |   Die Nutzung der Inhalte ist ausschließlich für den privaten Gebrauch bestimmt. Die über den persönlichen Gebrauch hinausgehende Vervielfältigung und Verbreitung ist nicht gestattet.
Impressum   |   Datenschutzerklärung   |   AGB   |   Kontakt   |   Cookie Einstellungen

Accessibility by WAH